MoneyWorks4Me

Revenue showed a marginal decline at Rs. 1025.61 millions. For the quarter ended December 2023, as compared to corresponding quarter of last year.The Net Loss for the quarter ended December 2023 is Rs. -149.66 millions as compared to Net Loss of Rs. -10.32 millions of corresponding quarter ended December 2022The Operating Profit of the company witnessed a decrease to 71.08 millions from 210.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1025.61 1065.86 -3.78 3670.15 3050.79 20.30 4109.58 3977.14 3.33
Other Income 26.21 32.02 -18.14 114.03 55.75 104.54 118.54 235.45 -49.65
PBIDT 71.08 210.96 -66.31 454.29 396.54 14.56 538.87 688.94 -21.78
Interest 152.97 148.39 3.09 485.07 452.83 7.12 597.62 571.59 4.55
PBDT -81.89 62.57 -230.88 -30.78 -56.29 -45.32 547.04 124.69 338.72
Depreciation 67.77 72.89 -7.02 202.32 214.30 -5.59 286.68 320.73 -10.62
PBT -149.66 -10.32 1350.19 -233.10 -270.59 -13.85 260.36 -196.04 -232.81
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.18 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -149.66 -10.32 1350.19 -233.10 -270.59 -13.85 260.36 -200.22 -230.04
Equity 108.33 108.33 0.00 108.33 108.33 0.00 108.33 108.33 0.00
PBIDTM(%) 6.93 19.79 -64.98 12.38 13.00 -4.77 13.11 17.32 -24.30
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..